secwatch.observer — SEC 8-K summary
======================================

Issuer:     QT IMAGING HOLDINGS, INC. (QTI)
CIK:        0001844505
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0001844505-24-000076
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QT Imaging Q3 scanner sales $0.9M (65% gross margin); amends convertible note to $8.6M; insider PIPE $2.56M
--------------------------------------------------------------------------------

- Generated $0.9M scanner sales revenue with 65% gross margin in Q3 2024.
- Completed engineering and clinical feasibility study with strategic partner.
- Amended $10M convertible note with YA II PN: principal reduced to $8.6M, maturity extended to March 2026.
- Board members and affiliates invested $2.56M PIPE at ~10% premium; surrened $1.56M note and $1M new cash.
- Third-year renewal of NIH/NCI research grant signed during quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844505/000184450524000076/0001844505-24-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844505/000184450524000076/qti-20241113.htm
  HTML page:      https://secwatch.observer/filing/0001844505-24-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer